RE: Effects of testosterone replacement on response to sildenafil citrate

Annals of Internal Medicine

Volumn 158, Issue 7, 2013, Pages 569-570

  Aversa, Antonio ^a   Jannini, Emmanuele A ^a   Maggi, Mario ^a   Lenzi, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; TESTOSTERONE; ANDROGEN; PHOSPHODIESTERASE V INHIBITOR; PIPERAZINE DERIVATIVE; SULFONE;

DOPPLER ECHOGRAPHY; ERECTILE DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; LETTER; MOTIVATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE; MALE; NOTE;

ANDROGENS; ERECTILE DYSFUNCTION; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; SULFONES; TESTOSTERONE;

EID: 84875743356     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-7-201304020-00018     Document Type: Letter

References (5)

1. Spitzer M, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunc-tion: a parallel, randomized trial. Ann Intern Med. 2012;157:681-91.
2. Carosa E, Martini P, Brandetti F, Di Stasi SM, Lombardo F, Lenzi A, et al. Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. Clin Endocrinol (Oxf). 2004;61:382-6.
3. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin En-docrinol (Oxf). 2003;58:632-8.
4. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2008;179:S97-S102.
5. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora caver-nosa. Endocrinology. 2004;145:2253-63.